Dexcel Pharma
Asia, Yerushalayim, Israel, Jerusalem
Description
Dexcel Pharma is an international specialty pharmaceutical company.
Investor Profile
Dexcel Pharma has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Private Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series A (29%)
- Private Equity (29%)
- Series B (14%)
- Series C (14%)
- Series Unknown (14%)
Country Focus
- United States (86%)
- Israel (14%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Biopharma
- Pharmaceutical
- Product Research
- Analytics
- Artificial Intelligence (Ai)
- Machine Learning
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
